Prevalence of Oral Lesions and Their Association with Systematic Diseases Among Children
DOI:
https://doi.org/10.51699/vtjbsm14Keywords:
Oral lesions, Oral candidiasis, Aphthous ulcers, children, Pediatric oral healthAbstract
Background: Pediatric oral lesions vary by developmental stage and sex, yet their distribution remains insufficiently characterized in young clinical populations worldwide. Aims of the study: This study aimed to characterize oral lesion patterns and examine their distribution according to age and sex among children. Methodology: This descriptive cross-sectional study included 14 children who underwent clinical oral examination at Azadi Teaching Hospital between January 3, 2026, and October 10, 2026. Children with complete demographic and diagnostic records were eligible, while incomplete or duplicated records were excluded. A trained clinician examined participants under adequate illumination using sterile instruments. Lesions were evaluated according to clinical appearance, anatomical location, and presenting features, then classified as oral candidiasis, aphthous ulcers, or viral oral infection. Age was analyzed continuously and categorized as <1, 1–<2, 2–<3, and ≥3 years. Result: The study included 14 children (mean age, 1.55±1.01 years), of whom 64.3% were female. Oral candidiasis was the predominant lesion, accounting for 71.4% of cases, whereas aphthous ulcers and viral infections each represented 14.3%. Candidiasis occurred in 66.7% of females and 80.0% of males. Lesion distribution did not differ significantly by sex (P=0.760) or age (P=0.210). Candidiasis was particularly frequent among children younger than two years, although subgroup estimates were limited by the small sample size and wide confidence intervals. Conclusions: Oral candidiasis predominated, particularly among children younger than two years. Lesion patterns were not significantly associated with age or sex. Larger population-based studies incorporating healthy controls, microbiological confirmation, and systemic clinical factors are needed to validate these preliminary findings.
References
[1] H. Yao, Q. Song, Q. Zhang, G. Tang, and M. Liu, “Prevalence of oral mucosal lesions in children in Xiangyun of Yunnan, China: A cross-sectional study,” Ital. J. Pediatr., vol. 48, no. 1, p. 15, 2022, doi: 10.1186/s13052-022-01209-6.
[2] E. Vélez-León, A. Albaladejo, E. Guerrero, G. Galván, and M. Melo, “Intraoral soft tissue lesions in 6-year-old schoolchildren in regions of southern Ecuador: An epidemiological study,” Children (Basel), vol. 11, no. 4, p. 406, 2024, doi: 10.3390/children11040406.
[3] S. Capodiferro, L. Limongelli, and G. Favia, “Oral and maxillo-facial manifestations of systemic diseases: An overview,” Medicina (Kaunas), vol. 57, no. 3, p. 271, 2021, doi: 10.3390/medicina57030271.
[4] S. G. AlHarbi, A. S. Almushayt, S. Bamashmous, T. S. Abujamel, and N. O. Bamashmous, “The oral microbiome of children in health and disease: A literature review,” Front. Oral Health, vol. 5, Art. no. 1477004, 2024, doi: 10.3389/froh.2024.1477004.
[5] P. García-Ríos, M. P. Pecci-Lloret, and R. E. Oñate-Sánchez, “Oral manifestations of systemic lupus erythematosus: A systematic review,” Int. J. Environ. Res. Public Health, vol. 19, no. 19, Art. no. 11910, 2022, doi: 10.3390/ijerph191911910.
[6] L. Ferizi, V. Bimbashi, and J. Kelmendi, “Association between metabolic control and oral health in children with type 1 diabetes mellitus,” BMC Oral Health, vol. 22, no. 1, p. 502, 2022, doi: 10.1186/s12903-022-02555-x.
[7] P. Schädlich, J. Symmank, A. Dost, C. Jacobs, and Y. Wagner, “Oral health of children and adolescents with diabetes mellitus,” J. Clin. Med., vol. 13, no. 22, p. 6742, 2024, doi: 10.3390/jcm13226742.
[8] Z. Triebl, B. Bencze, D. Bányai, N. Rózsa, P. Hermann, and D. Végh, “Poor glycemic control impairs oral health in children with type 1 diabetes mellitus: A systematic review and meta-analysis,” BMC Oral Health, vol. 24, no. 1, p. 748, 2024, doi: 10.1186/s12903-024-04516-y.
[9] L. Villemur Moreau, O. Dicky, E. Mas, E. Noirrit, M. Marty, F. Vaysse, et al., “Oral manifestations of celiac disease in French children,” Arch. Pediatr., vol. 28, no. 2, pp. 105–110, 2021, doi: 10.1016/j.arcped.2020.11.002.
[10] F. A. Alsadat, N. M. Alamoudi, A. A. El-Housseiny, O. M. Felemban, F. M. Dardeer, and O. I. Saadah, “Oral and dental manifestations of celiac disease in children: A case–control study,” BMC Oral Health, vol. 21, no. 1, p. 669, 2021, doi: 10.1186/s12903-021-01976-4.
[11] H. Wieser, M. Amato, M. Caggiano, and C. Ciacci, “Dental manifestations and celiac disease—An overview,” J. Clin. Med., vol. 12, no. 8, p. 2801, 2023, doi: 10.3390/jcm12082801.
[12] P. Filetici, S. G. Gallottini, A. Corvaglia, M. Amendolea, R. Sangiovanni, F. Nicoletti, et al., “The role of oral microbiota in the development of oral mucositis in pediatric oncology patients treated with antineoplastic drugs: A systematic review,” BMC Oral Health, vol. 24, no. 1, p. 183, 2024, doi: 10.1186/s12903-024-03938-y.
[13] R. Braguês, M. F. Marvão, P. Correia, and R. M. Silva, “Oral mucositis management in children under cancer treatment: A systematic review,” Cancers (Basel), vol. 16, no. 8, p. 1548, 2024, doi: 10.3390/cancers16081548.
[14] J. E. Owczarek-Drabińska, P. Nowak, M. Zimoląg-Dydak, and M. Radwan-Oczko, “The prevalence of oral mucosa lesions in pediatric patients,” Int. J. Environ. Res. Public Health, vol. 19, no. 18, Art. no. 11277, 2022, doi: 10.3390/ijerph191811277.
[15] C. Guillouet, M. C. Riou, L. T. Duong, M. de La Dure-Molla, and B. P. J. Fournier, “Oral lesions of viral, bacterial, and fungal diseases in children: A decision tree,” Front. Pediatr., vol. 10, Art. no. 937808, 2022, doi: 10.3389/fped.2022.937808.
[16] M. F. Mushi, N. Loi, and S. E. Mshana, “Oral candidiasis in HIV-uninfected pediatric populations in areas with limited fungal diagnosis: A case study from a tertiary hospital in Tanzania,” Ther. Adv. Infect. Dis., vol. 8, Art. no. 20499361211016964, 2021, doi: 10.1177/20499361211016964.
[17] N. Alkhars, Y. Zeng, N. Alomeir, N. Al Jallad, T. T. Wu, S. Aboelmagd, et al., “Oral Candida predicts Streptococcus mutans emergence in underserved US infants,” J. Dent. Res., vol. 101, no. 1, pp. 54–62, 2022, doi: 10.1177/00220345211012385.
[18] M. Doğan, Ü. M. Şahiner, A. S. Ataç, E. Ballıkaya, Ö. U. Soyer, and B. E. Şekerel, “Oral health status of asthmatic children using inhaled corticosteroids,” Turk. J. Pediatr., vol. 63, no. 1, pp. 77–85, 2021, doi: 10.24953/turkjped.2021.01.009.
[19] S. C. Kakoschke, S. Fleschutz, E. Ruff, K. Dichtl, M. Groeger, C. Schoen, et al., “Pediatric Candida manifestations in the orofacial region: A retrospective analysis of different forms, risk factors and species distribution,” J. Fungi, vol. 11, no. 5, p. 363, 2025, doi: 10.3390/jof11050363.
[20] C. Légeret and R. Furlano, “Oral ulcers in children—A clinical narrative overview,” Ital. J. Pediatr., vol. 47, p. 144, 2021, doi: 10.1186/s13052-021-01097-2.
[21] M. D’Amario, G. Foffo, F. Grilli, M. Capogreco, T. Pizzolante, and S. Rastelli, “Treatments for recurrent aphthous stomatitis: A literature review,” Dent. J., vol. 13, no. 2, p. 66, 2025, doi: 10.3390/dj13020066.
[22] M. Klichowska-Palonka, A. Komsta, and E. Pac-Kożuchowska, “The condition of the oral cavity at the time of diagnosis of inflammatory bowel disease in pediatric patients,” Sci. Rep., vol. 11, Art. no. 21898, 2021, doi: 10.1038/s41598-021-01370-8.
[23] M. P. Pecci-Lloret, E. Ramirez-Santisteban, A. Hergueta-Castillo, J. Guerrero-Gironés, and R. E. Oñate-Sánchez, “Oral manifestations of Crohn’s disease: A systematic review,” J. Clin. Med., vol. 12, no. 20, p. 6450, 2023, doi: 10.3390/jcm12206450.
[24] M. A. Shazib, K. M. Byrd, A. S. Gulati, et al., “Diagnosis and management of oral extraintestinal manifestations of pediatric inflammatory bowel disease,” J. Pediatr. Gastroenterol. Nutr., vol. 74, no. 1, pp. 7–12, 2022, doi: 10.1097/MPG.0000000000003302.
[25] S. C. Soares, L. J. D. Roux, A. R. Castro, C. C. Silva, R. Rodrigues, V. M. P. Macho, F. Silva, and C. Costa, “Oral manifestations: A warning sign in children with hematological disease—Acute lymphocytic leukemia,” Hematol. Rep., vol. 15, no. 3, pp. 491–502, 2023, doi: 10.3390/hematolrep15030051.
[26] B. B. Silveira, L. C. Melo, J. Amorim Dos Santos, et al., “Oral manifestations in pediatric patients with leukemia: A systematic review and meta-analysis,” J. Am. Dent. Assoc., vol. 155, no. 10, pp. 858–870.e30, 2024, doi: 10.1016/j.adaj.2024.07.014.
[27] A. E. Moca, R. I. Juncar, R. T. Moca, T. Bota, D. T. Sabău, and M. Juncar, “Oral manifestations in children diagnosed with COVID-19: A narrative review,” Healthcare, vol. 11, no. 3, p. 288, 2023, doi: 10.3390/healthcare11030288.
[28] F. Di Spirito, F. D’Ambrosio, M. P. Di Palo, F. Giordano, N. Coppola, and M. Contaldo, “COVID-19 and related vaccinations in children: Pathogenic aspects of oral lesions,” Children, vol. 10, no. 5, p. 809, 2023, doi: 10.3390/children10050809.
[29] W. Y. Kot, J. W. Li, A. K. Y. Chan, and L. W. Zheng, “A reflection on COVID-19 and oral mucosal lesions: A systematic review,” Front. Oral Health, vol. 4, Art. no. 1322458, 2023, doi: 10.3389/froh.2023.1322458.
[30] E. Kirubakaran, S. Shan, V. K, S. Haridoss, and K. Swaminathan, “Oral manifestations in children with neutropenia: A systematic review,” Cureus, vol. 17, no. 8, Art. no. e89721, 2025, doi: 10.7759/cureus.89721.
[31] I. M. Teodorescu, E. Preoteasa, C. T. Preoteasa, C. Murariu-Măgureanu, and C. Teodorescu, “Association of systemic pathologies with dental, periodontal, and orthodontic status in children,” Biomedicines, vol. 13, no. 9, p. 2137, 2025, doi: 10.3390/biomedicines13092137.
[32] National Institute of Dental and Craniofacial Research, Oral Health in America: Advances and Challenges. National Institutes of Health, U.S. Department of Health and Human Services, 2021. [Online]. Available: https://www.nidcr.nih.gov/research/oralhealthinamerica
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Media Assi Hussien Ali, Azmar Sheraz Safaa Al Talabani

This work is licensed under a Creative Commons Attribution 4.0 International License.
